chrisvoncsefalvay/vaers-outcomes huggingface dataset:
titers were drawn for varicella, the titers were found to be negative.; The patient developed a rash with several vesicles an unknown period of time after receiving the vaccine combination.; The patient developed a rash with several vesicles an unknown period of time after receiving the vaccine combination.; "home brewed combination vaccine that combined"; This spontaneous report was received from a nurse practitioner (also reported as a physician assistant) via a field representative referring to a currently 12 years old female patient. Information about pertinent medical history, drug reactions/allergies and concomitant medication was unknown.  On an unknown date in the past, the patient was vaccinated with a home brewed combination vaccine that combined varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) subcutaneously (dose detail, lot # and expiration date were not reported for both) for prophylaxis (reported as vaccination) (Wrong technique in product usage process).  On an unknown date, after received the combination vaccine of varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), the patient developed a rash with several vesicles for an unknown period. On an unknown date, in recently, the patient was seen at the physician's office, where titers were drawn for varicella. The titers were found to be negative. On an unknown date (also reported as in a recent date), the patient was given a dose of varicella virus vaccine live (oka/merck) (VARIVAX) via subcutaneously (dose detail, lot # and expiration date were not reported) for prophylaxis as a result.   It was unknown if treatment was given for the events. The outcome of rash, several vesicles and titers was negative was reported as recovered. The causality assessment between ash, several vesicles, titers negative and suspect vaccines were not reported.
I got COVID-19 on December 31, 2021. It lasted about 5 days.  This was confirmed by both Rapid Test and PCR.  I was home ill (headache, chills, joint pain, lowgrade fever, tinnitus, abdominal pain).
numbness in his arm at the injection site; He also complained of shortness of breath; tingling in his arm at the injection site; One of my LPNs administered a dose of Moderna Covid-19 vaccine 0.25mL booster to a 14 yo patient.; This spontaneous case was reported by a nurse and describes the occurrence of VACCINATION SITE ANAESTHESIA (numbness in his arm at the injection site), DYSPNOEA (He also complained of shortness of breath), VACCINATION SITE PARAESTHESIA (tingling in his arm at the injection site) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (One of my LPNs administered a dose of Moderna Covid-19 vaccine 0.25mL booster to a 14 yo patient.) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028K21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: Pfizer (2nd dose (full dose)) and Pfizer (1st dose (full dose)). Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer.    On 27-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 27-Jan-2022, the patient experienced VACCINATION SITE ANAESTHESIA (numbness in his arm at the injection site), DYSPNOEA (He also complained of shortness of breath), VACCINATION SITE PARAESTHESIA (tingling in his arm at the injection site) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (One of my LPNs administered a dose of Moderna Covid-19 vaccine 0.25mL booster to a 14 yo patient.). At the time of the report, VACCINATION SITE ANAESTHESIA (numbness in his arm at the injection site), DYSPNOEA (He also complained of shortness of breath) and VACCINATION SITE PARAESTHESIA (tingling in his arm at the injection site) had resolved and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (One of my LPNs administered a dose of Moderna Covid-19 vaccine 0.25mL booster to a 14 yo patient.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.
Administered Moderna COVID-19 Vaccine to a 17 year old patient; A spontaneous report was received from a healthcare facility staff member, concerning a 17-year-old, who was administered Moderna's COVID-19 vaccine (mRNA-1273) (PT: Product administered to patient of inappropriate age).  The patient's medical history was not provided. No relevant concomitant medications were reported.   On 07 Jan 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown)intramuscularly for prophylaxis of COVID-19 infection.  On 07 Jan 2021, the 17-year-old patient was administered their first dose of vaccine. No additional information was provided. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event, administered Moderna COVID-19 Vaccine to a 17-year-old patient, was considered resolved on 07 Jan 2021.; Reporter's Comments: This case concerns a 17-year-old patient of unknown gender who received their first of two planned doses of mRNA-1273 (Lot # unknown), reporting Product administered to patient of inappropriate age without any associated adverse events. Event considered resolved.
This is a spontaneous report received from a contactable consumer or other non-HCP (patient). A 55-year-old female patient (not pregnant) received the 1st dose of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), at the age of 55, in left arm, on Mar 17, 2021, at 18:00, single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed fatigue (tired), onset Mar 17, 2021, with outcome of unknown; headache and nausea/nauseous, onset Mar 17, 2021, with outcome of not recovered. No therapeutic measures taken as a result of fatigue, headache and nausea. Additional information: Patient's left arm was sore. She was nauseous, had a headache and felt really, really tired for a couple of weeks. No treatment received. No COVID-19 diagnosis prior vaccination. No COVID-19 test post vaccination. No follow-up attempts possible. No further information expected.
developed covid  07/04/2021, cough, sore throat, myalgias, fatigue, nausea, loss of smell
24 hours after administration patient reported a 4x4 indurated area from the vaccine on her left arm. We treated patient virtually after reviewing pictures she sent to us of her arm and felt she was having  an acute local reaction to the vaccine. Next steps: 1) Tylenol for pain 2) Cold cloth over the area for some relief 3) Monitor for any fevers, headache, fatigue. Patient reported no fever, headache or fatigue. The following morning patient reported to us with updated pictures and said the entire red area is warm, sore, and itchy. Redness/warmth has spread from initial induration to elbow over night. PCP recommended Start Bactrim DS BID, Start Prednisone 20 mg q am x 5 days, Start Benadryl/Zyrtec, Tylenol prn pain. Monitor size with circle, contact us immediately if any change, fever, chills. 72 hours after administration patient reported warmth and redness still spreading despite 2 doses of bactrim, steroids, and Zyrtec. PCP advised patient to seek consult at an urgent care or ER.
DOB was incorrect so nurse thought patient was 12 month old and not 9 month and gave vaccines according to 12 month old schedule
Vasovagal response - Faint, dizzy, weakness, started immediately after immunization. Patient was given a snack and water, and monitored for 30 minutes post vaccination. No further side effects noted.
A non-serious case was received from a health professional in the United States on 15 May 2007. two female adolescent patients developed extensive limb swelling and redness at the injection site after receiving intramuscular injections of Menactra (lot numbers not reported). Patient one experienced "bright redness at the injection site and surrounding area" with "swelling of entire limb of injection site"; patient two experienced "bright redness at injection site" and "extreme swelling of upper arm where injection given". No additional information was provided, and the outcome was unknown. A corrective version was created using the receipt date 15 May 2007. This case now captures only one female adolescent patient who experienced right redness at the injection site and surrounding area" with "swelling of entire limb of injection site". An additional non-serious event of Extensive limb swelling and Injection site redness was reported by this health professional and is captured in case number 200701775.
Started out feeling like bronchitis, went to Urgent care for antibiotics and a steroid.  This was January 1, 2022.  5-6 days later I couldn?t breath as lungs filled with fluid.  Urgent care provided a shot of Dexamethozone, Teflon pearls and a Zpack.  Zpack and Teflon pearls had no noticeable effect.  Dexomethozone let me breath a little better.  I felt like I couldn?t breathe and had a cough that didn?t produce anything.  14 days later, I got covid again.  Great deal of fatigue.  I felt like I was having an athsma attack, but inhaler did not work.  I could not breath or talk.  Only managed to say one word before losing breath.  On a short dose of Dexamethozone from February to April.  There is a blockage in lung and heart is not getting enough oxygen.  Xrays on January 1st show covid pneumonia.  4/13 cat scan showed a broken rib with gray matter in lungs.  On breathing treatments, albuterol and steroid.  Felt like lungs weren?t fulling inflating.  Mid April things cleared up.
swelling of lt arm from waist to above shoulder & extending over to lt scapula-tenderness on palpation not indurated, sl erythema;no streaking;
1 of 2 pts vaxed from the same lot# who exp an inj site rxn;pt exp erythema & induration approx 2cm in diameter following 1st pneumococcal vax;not seen by MD;pt recovered;
so sick; was that awful; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine with an associated reaction of illness (received 1st dose on an unknown date and experienced illness and felt awful, refer case US2021AMR176096).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness and feeling bad. Rechallenge with Shingles vaccine was positive. On an unknown date, the outcome of the sickness and feeling bad were unknown.   It was unknown if the reporter considered the sickness and feeling bad to be related to Shingles vaccine.  Additional details were provided as follows: This case was reported by patient himself/herself. The age at vaccination was not reported. The patient received 2nd shot and was so sick and experienced severe side effects. The patient said he/she would not do that again. The patient said he/she would never had taken the shots if his/her body would react, it was awful.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176096:Same reporter
No additional AEs; Vaccine was administered after data logger discrepancy; This spontaneous report was received from an other reporter and referred to a patient with unknown age and gender. The patient's concurrent conditions, concomitant medication, pertinent medical history and drug reactions/ allergies were not provided.  On an unknown date, measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was improperly stored and occurred data logger discrepancy. Temperature, time frame and previous temperature excursion were unknown. On 25-APR-2023, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (rHA) (1 dosage form, lot # W034211 has been verified to be a valid lot number, expiration date was reported as 24-APR-2024, anatomical location and route were not provided) for prophylaxis after data logger discrepancy (product storage error). No additional adverse event (AE) reported (no adverse event).
17 Nov 04 Pt is 20 year old male primary vaccine who received his smallpox vaccine on 14 Sep 04. On 21 Sep 04, he began to experience chest pain. The pain was described as dull initially and gradually increased over the next 2 days to become a severe stabbing pain. He denied radiation, nausea, vomiting, and shortness of breath. He state that the pain was worse when he would lay down and it eased when he sat up. He reported that the pain also increased with movement. He was hospitalized from Sep 24-28 for cardiac evaluation and he reports he was pain free upon discharge. He has currently been pain free for the past couple wks and only notices occasional shortness of breath while he is running. He states that he is getting stronger and denies fever, abd pain, headaches and myalgias. Chest Pain Start : 09/21/2004 End : 09/21/2004. Dyspnea (shortness of breath ) Start: 09/21/2004 End: 09/21/2004. -3/8/06 Review of 3-page d/c summary for admission of 9/24/04 indicates final diagnosis of myopericarditis. The 29-page medical record confirms that diagnosis. In the ER he was treated with morphine and indomethacin with resolution of chest pain. He was then placed on ibuprofen 800 mg tid and this was continued after his d/c from the hospital.  - 3/8/06 Review of 5-page d/c summary indicates patient was readmitted to hospital on 10/25/04 for recurrence of pleuritic chest pain. He was monitored overnight with no changes in EKG or enzymes and was restarted on ibuprofen which was to be taken for 3 weeks. Chest pain abated and patient was discharged on 10/28/04 with final diagnosis of persistent pericarditis. Review of 21-page medical record confirmed that diagnosis as well. 60 Day follow report indicates recovery status unknown, pt loss to F/U.
arm was swollen/arm was swollen; slept for 4 days; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination.     Concurrent medical conditions included COPD and Sinus infection.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days). At the time of the report, PERIPHERAL SWELLING (arm was swollen/arm was swollen) and HYPERSOMNIA (slept for 4 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to -MODERNATX, INC.-MOD-2021-083147 (E2B Linked Report).; Sender's Comments:  -MODERNATX, INC.-MOD-2021-083147:CROSSLINKED WITH DOSE 2
On 04/16/2021 I had a headache, fatigue, pain at the injection site, low fever, achy all over that lasted for about two days. On 04/30/2021 began having a pain down my neck, I still have them to this day, but off and on. It sometimes wakes me out of sleep or keeps me from falling asleep.
Initially started with migratory hives that were extremely itchy. Benadryl did not help. After 24 hours of continuous itch, zyrtec was taken. After zyrtec was taken the rash still continued but less severe. It presents as a raised red rash that migrates around the body sometimes itchy sometimes not. On day 9 of the rash and symptoms are still presenting. Doctor ordered steroid and to continue use of zyrtec.
Suspected vaccination failure; The patient then came down with shingles a few weeks ago; This serious case was reported by a physician via sales rep and described the occurrence of vaccination failure in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In FEB-2021, the patient received the 2nd dose of Shingrix. In OCT-2020, the patient received the 1st dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix and Shingrix, the patient experienced vaccination failure (Verbatim: Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: The patient then came down with shingles a few weeks ago).  The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingrix and Shingrix.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingrix and Shingrix.   Additional Information: GSK Receipt Date: 22-MAR-2023 The patient received Shingrix 1st dose and then 2nd dose.  The patient then came down with shingles a few weeks ago per the health care professional (hcp). This case was considered as suspected vaccination failure as details regarding time to onset and laboratory test confirming shingles were unknown at the time of reporting. The reporter consented to follow up.
I woke up at 5AM the morning after the vaccine, with hives and rash all over my face. I went to local emergency room.  They diagnosed me with "Moderna rash" and was prescribed to take Benadryl. I woke up one morning with welts on my face, breast and right arm. I took Benadryl and it help a little. I called a doctor who also diagnosed me with "Moderna rash" and to let it run its course and to take Benadryl and cold showers. It took about a week for the welts to improve. I had loss of appetite and flu like symptoms and extreme fatigue. It took about 10 days for the flu like symptoms to go away.
Transport to Hospital   At approximately 1905 hours at the vaccination site, a 23 YOM, Patient was vaccinated with his 1st dose of Pfizer after clearing all medical screening questions. Pt was AOx3 with a normal affect prior to the vaccination event.  Approximately 15 seconds after receiving his vaccination, pt became unconscious and slumped over in chair.  Pt was promptly attended to by clinicians and no fall occurred.  He woke up shortly after his syncopal episode.  Security were notified and Rescue was dispatched to the incident.  Detailed Pt information: Pt only medical history is celiac disease.  Pt has NKDA and no medications.  Pt admitted to drinking two beers and smoking marijuana earlier in the evening.  Pt became AOX3 approximately 30 seconds after the syncopal episode, however did not recall the event. Pt detailed exam included:   Vitals #1: BP: 122/94, P: 60, R:14 Skin: Pale, diaphoretic Vitals #2: BP: 90/60 P:58, R:14 Skin: Pale, diaphoretic  Rescue arrived on scene and patient care transferred.  Pt was loaded into ambulance and transported to hospital.
A 68 year old male received RSV vaccine or Placebo and Influenza Vaccine on 10/16/02 and 205 days later died on 5/9/03. Investigator was notified by patient's family that he died at home. Will speak to family in a couple of weeks. The Investigator assessed the event as unrelated to the study product. Follow up on 07/08/2003: "A 68 year old male received RSV vaccine or Placebo and Influenza vaccine on 10/16/2002 and 205 days later died on May 9, 2003.  Investigator was notified by patient's family that he died at home.  Will speak to family in a couple weeks.  The investigator assessed the event as unrelated to the study product.  Follow up information received 07/01/2003.  Investigator spoke with family members regarding death.  Death certificate lists CHF as cause of death.  Subject went from a lengthy hospitalization to a nursing home where he died approximately 1 week later.  Prior hospitalization in File # 2003-00364.  The Investigator assessed the event as unrelated to the study product. HISTORY OF PRESENT ILLNESS:  The patient is a 68 year old white male well known to me who is being admitted to hospital for acute syncope with resultant facial contusions and left knee contusion.  The patient was seen by myself last week in the ofice for his usual followup and also had an episode of either slipping vs. syncope with resultant left facial contusion and left conjuctival hemorrhage.  He was back to his baseline status and saw doctor at hospital today who is his cardiologist.  He suggested placing him on a Holter monitor because of the facial ontusion and questionable syncopal episode.  The patient left the hospital.  Apparently, the patient became lightheaded and passed out.  He landed on his face and chest and does not recall any events thereafter until he was at the hospital.  He was complaning of chest discomfort which he felt was due to contusing his chest but was treated as if it was cardiac in origin with aspirin, Nitroglycerin paste and morphine.  He also was placed in a left knee immobilizer.  He underwent a CAT scan of his head which was normal.  Chest x-ray revealed questionable mild congestive heart failure.  His labs are notable for his usual chronic renal insufficiency, hypoatremia, hypoalemia and an elevated white count of 14,000.  It was determined that the patient needed to be further evaluated due to his complicated history as well as syncope and possible cardiac issues.  He has since been transferred to a other hospital where he is presently complaining left knee discomfort and mild palpable chest discomfort.  He is not short of breath and is frustrated with the overall situation.
Dizziness & Angina At approx 0912, the employee began to complain of chest pain 10 mins post vaccine. Points to top of chest, states pain is a sharp pain 7/10. Vital signs assessed BP 133/84, HR 92, O2-97 via room air. RR- 18. Code assist is called. After approx 12 mins employee states that pain is now radiating to left side and is experiences dizziness and lightheadedness. Employee denies any history of chest pain. 0917, repeat vitals BP 122/82, O2-97 via room air, RR- 16 pain 7/10. Pt now reports pain is radiating to both side of chest. Pt left via wheelchair with ER staff in stable condition.
Vomiting x 24 hours after receiving TDAP and MMR.  (Mom requested that we report).
got covid on april 7; sick till April 26; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (got covid on april 7) and ILLNESS (sick till April 26) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No relevant medical history provided.     On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced COVID-19 (got covid on april 7) and ILLNESS (sick till April 26). On 26-Apr-2021, COVID-19 (got covid on april 7) and ILLNESS (sick till April 26) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided.  Treatment information was not provided.